These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28300888)

  • 1. Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis.
    Pereira AR; Moura LH; Pinheiro JR; Pasin VP; Enokihara MM; Porro AM
    An Bras Dermatol; 2016; 91(5 suppl 1):35-38. PubMed ID: 28300888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A toxic epidermal necrolysis-like presentation of linear IgA bullous dermatosis treated with dapsone.
    Nguyen JK; Koshelev MV; Gill BJ; Boulavsky J; Diwan AH; Dao H
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.
    Lammer J; Hein R; Roenneberg S; Biedermann T; Volz T
    Acta Derm Venereol; 2019 May; 99(6):508-515. PubMed ID: 30809685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced linear IgA bullous dermatosis simulating toxic epidermal necrolysis.
    Nasr J; Ammoury A; Chouairy C; Mégarbané H; El Habr C
    J Med Liban; 2014; 62(3):176-9. PubMed ID: 25306799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
    Dellavalle RP; Burch JM; Tayal S; Golitz LE; Fitzpatrick JE; Walsh P
    J Am Acad Dermatol; 2003 May; 48(5 Suppl):S56-7. PubMed ID: 12734475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Baltazard T; Dhaille F; Duvert-Lehembre S; Lok C; Chaby G
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
    Hughes AP; Callen JP
    Dermatology; 2001; 202(2):138-9. PubMed ID: 11306837
    [No Abstract]   [Full Text] [Related]  

  • 8. Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
    Adler NR; McLean CA; Aung AK; Goh MS
    Clin Exp Dermatol; 2017 Apr; 42(3):299-302. PubMed ID: 28084616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin-induced linear Immunoglobulin A bullous dermatosis.
    Phyu H; Kobayashi T; Rastogi P; Cho C
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31822537
    [No Abstract]   [Full Text] [Related]  

  • 10. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Waldman MA; Black DR; Callen JP
    Clin Exp Dermatol; 2004 Nov; 29(6):633-6. PubMed ID: 15550142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
    Billet SE; Kortuem KR; Gibson LE; El-Azhary R
    Arch Dermatol; 2008 Jun; 144(6):774-8. PubMed ID: 18559768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear IgA bullous dermatosis: a rare side effect of vancomycin.
    Selvaraj PK; Khasawneh FA
    Ann Saudi Med; 2013; 33(4):397-9. PubMed ID: 22750770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced linear IgA bullous dermatosis.
    Navi D; Michael DJ; Fazel N
    Dermatol Online J; 2006 Sep; 12(5):12. PubMed ID: 16962027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome.
    Jones DH; Todd M; Craig TJ
    J Am Osteopath Assoc; 2004 Apr; 104(4):157-63. PubMed ID: 15127983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
    Coelho S; Tellechea O; Reis JP; Mariano A; Figueiredo A
    Int J Dermatol; 2006 Aug; 45(8):995-6. PubMed ID: 16911399
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
    Adachi M; Adachi T; Yokota M; Ichimura C; Yoshida K; Ishii K; Ishiko A
    J Dermatol; 2021 Dec; 48(12):e610-e611. PubMed ID: 34561902
    [No Abstract]   [Full Text] [Related]  

  • 17. Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels.
    Walsh SN; Kerchner K; Sangüeza OP
    Arch Dermatol; 2009 May; 145(5):603-4. PubMed ID: 19451516
    [No Abstract]   [Full Text] [Related]  

  • 18. Vancomycin-Induced Linear IgA Bullous Dermatosis.
    Go JR; Abu Saleh OM
    N Engl J Med; 2020 Oct; 383(16):1577. PubMed ID: 33053287
    [No Abstract]   [Full Text] [Related]  

  • 19. False-negative direct immunofluorescence testing in vancomycin-induced linear IgA bullous dermatosis: a diagnostic pitfall.
    Winn AE; Spillane EL; Peterson DJ; Sperling LC; Meyerle JH
    J Cutan Pathol; 2016 Sep; 43(9):802-4. PubMed ID: 27354289
    [No Abstract]   [Full Text] [Related]  

  • 20. Linear immunoglobulin A dermatosis mimicking toxic epidermal necrolysis: a case report of etanercept treatment.
    Prieto-Barrios M; Velasco-Tamariz V; Tous-Romero F; Burillo-Martinez S; Zarco-Olivo C; Rodriguez-Peralto JL; Ortiz-Romero PL
    Br J Dermatol; 2018 Mar; 178(3):786-789. PubMed ID: 28222222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.